Amyloid-beta PET utility in Alzheimer’s desease / Symposium CANM Annual Conference 2022
Вставка
- Опубліковано 18 вер 2024
- Symposium CANM (Canadian Association of Nuclear Medecine) Annual Conference 2022
1st October 2022
Speaker : Nazanin Mirzaei Ph.D
Amyloid-beta PET utility on Alzheimer’s desease Neuraceq ® (florbetaben F18 injection)
LMI approved imaging agent for diagnosis of Alzheimer’s desease